Pediatric Mebendazole 100mg

Specially formulated 100mg Mebendazole tablets designed for pediatric patients and multi-day therapy regimens. Child-friendly dosage with proven efficacy and safety profile.

Pediatric Use Multi-Day Therapy Child Friendly WHO Recommended

Request Pediatric Quote WHO Guidelines

Mebendazole Tablets 100mg for Pediatric Use

Pediatric Indications & Usage

Primary Indications for Children

Roundworm (Ascaris lumbricoides)

Common in children aged 1-12 years, especially in developing regions with poor sanitation.

Pinworm (Enterobius vermicularis)

Highly prevalent in school-age children, causing intense perianal itching and sleep disturbances.

Hookworm (Ancylostoma duodenale)

Causes iron deficiency anemia in children, particularly in tropical and subtropical regions.

Whipworm (Trichuris trichiura)

Leads to chronic diarrhea and growth retardation in infected children.

Dosage Guidelines

Age Group	Dosage	Duration	Frequency
1-2 years	100mg	1 day	Single dose
2-12 years	100mg	1 day	Single dose
Adults & Children >12	100mg	3 days	Twice daily
Heavy Infections	100mg	3 days	Twice daily

Note: Dosage may vary based on local resistance patterns and physician discretion. Always follow healthcare provider recommendations.

Multi-Day Therapy Advantages

Higher Cure Rates

Multi-day therapy achieves up to 95% cure rates for heavy infections compared to 70-80% with single-dose therapy.

Pediatric Safety

100mg dosage specifically designed for children's body weight and metabolism with excellent safety profile.

Prevents Reinfection

Extended therapy duration helps prevent reinfection and breaks the parasite life cycle more effectively.

Child-Friendly Formulation

Formulation Characteristics

Strength:	100mg Mebendazole
Tablet Size:	6mm diameter (small, easy to swallow)
Taste:	Tasteless, uncoated
Splitting:	Scored for easy dose adjustment
Disintegration:	Rapid disintegration (<5 minutes)
Storage:	Room temperature, child-resistant packaging

Pediatric Safety Features

Low Side Effect Profile: Well-tolerated in children with minimal adverse reactions
No Drug Interactions: Safe with most common pediatric medications
Flexible Dosing: Can be crushed and mixed with food for children who cannot swallow tablets
WHO Prequalified: Listed on WHO Essential Medicines for Children
Cost-Effective: Affordable for mass deworming programs

Clinical Evidence & WHO Recommendations

WHO Prequalification

Mebendazole 100mg is WHO-prequalified for use in children aged 1-12 years for mass deworming programs.

Efficacy Studies

Clinical trials show 95% cure rates for common intestinal worms with multi-day 100mg therapy.

Safety Profile

Extensive safety data from millions of pediatric treatments worldwide with excellent tolerability.

Global Implementation

Used in national deworming programs across 45+ countries with proven effectiveness.

Global Supply for Pediatric Programs

Packaging Options for Children

Child-Resistant Blister Packs: 10 tablets per blister, safety sealed

Multi-Dose Bottles: 100 tablets with child-resistant caps

Institutional Packs: Bulk packaging for schools and clinics

Climate-Stable Packaging: Suitable for tropical regions

Program Support

Training Materials: Healthcare worker training for proper administration
Educational Materials: Parent-friendly information sheets
Monitoring Support: Program evaluation and reporting tools
Logistics Support: Cold chain not required, easy distribution

Supply Pediatric Deworming Programs Globally

Partner with Taj Pharma for WHO-prequalified Mebendazole 100mg tablets. Reliable supply, competitive pricing, and comprehensive program support for children's health initiatives.

Partner for Programs Government Tenders

Related Information

500mg Product

Adult formulation of Mebendazole Tablets for standard deworming therapy.

View 500mg

Types of Worms

Comprehensive guide to intestinal worms affecting children and adults.

Learn About Worms

WHO Guidelines

World Health Organization recommendations for deworming programs.

View Guidelines

Mebendazole Tablets 100mg